Migraine
Migraine is a neurological condition characterized by recurrent, severe headaches often accompanied by nausea, vomiting, and sensitivity to light and sound.
Atorvastatin for Preventing Episodic Migraines
We are studying whether atorvastatin can help reduce the frequency of episodic migraines in participants. This trial will also look at how well different doses work and any side effects that may occur.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 65 years old?
- Do you have 4 to 14 migraine days each month?
- Are you currently pregnant, planning to get pregnant, or breastfeeding?
- Are you taking any medications for migraine prevention, like Topiramate or Amitriptyline, within the last 4 weeks?
- Have you had migraine symptoms for at least one year before today?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Helse Bergen HF
Neurology
Bergen, Norway
Oslo University Hospital Hf
Neurology
Oslo, Norway
Oslo University Hospital HF
Neurology
Oslo, Norway
Sponsor: St. Olavs Hospital HF
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.